Bill Maughan
Stock Analyst at Clear Street
(0.14)
# 4,246
Out of 4,884 analysts
16
Total ratings
22.22%
Success rate
-40.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Initiates: Buy | $190 | $143.08 | +32.79% | 1 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Downgrades: Hold | $45 | $52.17 | -13.74% | 1 | Jun 27, 2025 | |
| YMAB Y-mAbs Therapeutics | Maintains: Buy | $26 | $4.30 | +504.65% | 2 | Aug 13, 2024 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $1.75 | +757.14% | 2 | May 10, 2024 | |
| FATE Fate Therapeutics | Maintains: Buy | $11 → $9 | $1.12 | +703.57% | 1 | May 10, 2024 | |
| IMCR Immunocore Holdings | Maintains: Hold | $63 → $67 | $33.02 | +102.91% | 3 | May 9, 2024 | |
| MRNA Moderna | Maintains: Hold | $91 → $106 | $30.49 | +247.65% | 3 | May 3, 2024 | |
| IPSC Century Therapeutics | Maintains: Buy | $22 → $24 | $0.56 | +4,223.55% | 1 | Mar 15, 2024 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $60 | $7.43 | +707.54% | 1 | Feb 21, 2024 | |
| MRUS Merus | Initiates: Buy | $45 | $53.82 | -16.39% | 1 | Nov 2, 2023 |
Krystal Biotech
Jul 1, 2025
Initiates: Buy
Price Target: $190
Current: $143.08
Upside: +32.79%
CRISPR Therapeutics AG
Jun 27, 2025
Downgrades: Hold
Price Target: $45
Current: $52.17
Upside: -13.74%
Y-mAbs Therapeutics
Aug 13, 2024
Maintains: Buy
Price Target: $26
Current: $4.30
Upside: +504.65%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $1.75
Upside: +757.14%
Fate Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.12
Upside: +703.57%
Immunocore Holdings
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $33.02
Upside: +102.91%
Moderna
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $30.49
Upside: +247.65%
Century Therapeutics
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $0.56
Upside: +4,223.55%
Bicycle Therapeutics
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $7.43
Upside: +707.54%
Merus
Nov 2, 2023
Initiates: Buy
Price Target: $45
Current: $53.82
Upside: -16.39%